Skip to content
value.today

Phosplatin Therapeutics LLC

Total raised
$72 M
3 rounds on record
Latest round
$37 M
Dec 2021
First round on record
Oct 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Phosplatin Therapeutics LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2021$37 MNo. 3$10 to $50 million

Phosplatin Therapeutics LLC: Raise no. 3, Dec 2021

Investors in this round

41 investors had bought by the notice of Dec 15, 2021: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frances Bonham · Executive Officer
  • Robert Fallon · Executive Officer, Director
  • Charles Stuckey · Director
  • Elizabeth Tallett · Director
  • John Caouette · Director
  • Matthew Price · Director
  • Neil Sunderland · Director
  • Peter Espig · Director
  • Rosita Leong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frances Bonham, Vice President of Finance and Administration. Newest notice filed Dec 15, 2021. Read the notice at the SEC.

equitySEC
Jul 2020$18 MNo. 2$10 to $50 million

Phosplatin Therapeutics LLC: Raise no. 2, Jul 2020

Investors in this round

40 investors had bought by the notice of Aug 14, 2020: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
$50,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Fallon Robert · Executive Officer, Director
  • Frances Bonham · Executive Officer
  • Matthew Price · Executive Officer, Director
  • John Caouette · Director
  • John Porter · Director
  • Neil Sunderland · Director
  • Peter Espig · Director
  • Rosita Leong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frances Bonham, Vice President of Finance & Administration. Newest notice filed Aug 14, 2020. Read the notice at the SEC.

debt, optionsSEC
Oct 2018$17 MNo. 1$10 to $50 million

Phosplatin Therapeutics LLC: Raise no. 1, Oct 2018

Investors in this round

48 investors had bought by the notice of Nov 8, 2018: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Frances Bonham · Executive Officer
  • Matthew Price · Executive Officer, Director
  • Robert Fallon · Executive Officer, Director
  • John Caouette · Director
  • John Porter · Director
  • Peter Espig · Director
  • Rosita Leong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frances Bonham, Vice President of Finance & Administration. Newest notice filed Nov 8, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Phosplatin Therapeutics LLC chose not to state its revenue in its newest notice of a funding round (Dec 2021).

    SEC Form D · Dec 2021

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Phosplatin Therapeutics LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Phosplatin Therapeutics LLC
NameRoleNamed in
Frances BonhamExecutive officerDec 2021
Robert FallonExecutive officerDec 2021
Fallon RobertExecutive officerAug 2020
Matthew PriceExecutive officerAug 2020
Charles StuckeyDirectorDec 2021
Elizabeth TallettDirectorDec 2021
John CaouetteDirectorDec 2021
Matthew PriceDirectorDec 2021
Neil SunderlandDirectorDec 2021
Peter EspigDirectorDec 2021
Robert FallonDirectorDec 2021
Rosita LeongDirectorDec 2021
Fallon RobertDirectorAug 2020
John PorterDirectorAug 2020